AC
ASB Consultores’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,857
| Closed | -$341K | – | 199 |
|
|
2024
Q4 | $341K | Buy |
12,857
+317
| +3% | +$8.41K | 0.14% | 123 |
|
|
2024
Q3 | $363K | Sell |
12,540
-3,018
| -19% | -$87.3K | 0.14% | 120 |
|
|
2024
Q2 | $435K | Sell |
15,558
-3,361
| -18% | -$94K | 0.16% | 87 |
|
|
2024
Q1 | $525K | Buy |
18,919
+11,659
| +161% | +$324K | 0.14% | 112 |
|
|
2023
Q4 | $209K | Sell |
7,260
-7,088
| -49% | -$204K | 0.07% | 105 |
|
|
2023
Q3 | $476K | Sell |
14,348
-4,161
| -22% | -$138K | 0.19% | 49 |
|
|
2023
Q2 | $679K | Buy |
18,509
+1,273
| +7% | +$46.7K | 0.33% | 59 |
|
|
2023
Q1 | $703K | Buy |
17,236
+5,567
| +48% | +$227K | 0.28% | 46 |
|
|
2022
Q4 | $598K | Sell |
11,669
-919
| -7% | -$47.1K | 0.25% | 50 |
|
|
2022
Q3 | $551K | Buy |
12,588
+1,511
| +14% | +$66.1K | 0.26% | 48 |
|
|
2022
Q2 | $581K | Buy |
11,077
+620
| +6% | +$32.5K | 0.25% | 44 |
|
|
2022
Q1 | $541K | Buy |
10,457
+118
| +1% | +$6.11K | 0.23% | 75 |
|
|
2021
Q4 | $611K | Buy |
+10,339
| New | +$611K | 0.3% | 65 |
|